𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P2-300: Inhibitors of cathepsin B for Alzheimer's disease therapeutics

✍ Scribed by Hook, Greg; Kindy, Mark; Hook, Vivian

Book ID
122047312
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
58 KB
Volume
4
Category
Article
ISSN
1552-5260

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Advances in the development of kinase in
Advances in the development of kinase inhibitor therapeutics for Alzheimer's disease
✍ Mary J. Savage; Diane E. Gingrich πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 576 KB

## Abstract Pharmaceutical approaches to slow the progression of Alzheimer's disease (AD) have focused primarily on reducing production or increasing clearance of amyloid Ξ² peptide (AΞ²). Recent clinical trial results question the efficacy of targeting AΞ² for treatment of mild to moderate AD, highli